NASDAQ:SOMX - Pernix Sleep Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Pernix Sleep Inc, formerly Somaxon Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of branded products and late-stage product candidates. The Company operates in one segment, which is the development and commercialization of pharmaceutical products. The Company's focus is on commercial activities relating to Silenor. As of December 31, 2011, the clinical development program for Silenor included four Phase III clinical trials. In June 2011, it entered into agreements with Paladin Labs Inc. (Paladin), under which Paladin had the right to commercialize Silenor in Canada, South America, the Caribbean and Africa, subject to the receipt of marketing approval in each such territory. In March 2013, Pernix Therapeutics Holdings Inc acquired the Company.

Receive SOMX News and Ratings via Email

Sign-up to receive the latest news and ratings for SOMX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SOMX
CUSIPN/A
Phone+1-302-6587581

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Pernix Sleep (NASDAQ:SOMX) Frequently Asked Questions

What is Pernix Sleep's stock symbol?

Pernix Sleep trades on the NASDAQ under the ticker symbol "SOMX."

Has Pernix Sleep been receiving favorable news coverage?

Headlines about SOMX stock have been trending neutral on Tuesday, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pernix Sleep earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave news coverage about the specialty pharmaceutical company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the stock's share price in the near term.

How do I buy shares of Pernix Sleep?

Shares of SOMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pernix Sleep's official website?

The official website for Pernix Sleep is http://www.somaxon.com/.

How can I contact Pernix Sleep?

Pernix Sleep's mailing address is 440 Stevens Ave Ste 200, SOLANA BEACH, CA 92075-2059, United States. The specialty pharmaceutical company can be reached via phone at +1-302-6587581.


MarketBeat Community Rating for Pernix Sleep (NASDAQ SOMX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  154
MarketBeat's community ratings are surveys of what our community members think about Pernix Sleep and other stocks. Vote "Outperform" if you believe SOMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SOMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Featured Article: Portfolio Manager

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel